Clinical Trials Browser

Adenocarcinoma of the Oesophagus × durvalumab × 1 year × Clear all

NCT02678182 2025-06-10

PLATFORM

Phase 2 Active not recruiting

Gastrointestinal

Adenocarcinoma of the Oesophagus